On this week's episode of "This Changes Things" we get a preview of the big stories coming out of CES in Las Vegas. Our own Jon Steinberg says it's the year of the voice assistant.
Monty Sharma, CEO of both Jenny Craig and Curves, shares what it takes to successfully turn a company around in a rapidly-changing industry like health and fitness. He says it all starts with the right team.
Then Pranav Yadav, CEO of neuromarketing firm Neuro-Insight, and George Slefo, Tech Reporter at Ad Age, take a look at innovations in the advertising industry. They discuss how new technology like brain mapping are improving the way companies target customers.
Plus, a look at some of the top female entrepreneurs to watch in 2018.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
